|
Bayous in Louisiana...
This picture
was selected to illustrate our programme as a nice symbol of the New Orleans
beauatiful surroundings. While it may now suggest more miseries than beauties,
we want to keep it here as a mark of sympathy to Louisiana population,
with the hope that Bayous will be soon again a real place of beauty
|
Short presentations
by young scientists
- P.A. Moise-Broder,
A. Forrest, J.J. Schentag (Buffalo, NY)
Relationship between time to eradication in vivo and bactericidal activity
in vitro of vancomycin for MRSA infections WEB
show - PDF
- S. Lemaire,
F. Van Bambeke, M.-P. Mingeot-Leclerq, Y. Glupczynski, P.M. Tulkens
(Brussels, Belgium)
Activity of carbapenems against intracellular MRSA - WEB
show - PDF
- J. Zack,
A. Forrest, S. Bilic, P. Kelchlin, P.F. Smith (Buffalo, NY)
PK/PD in silico & in vitro simulations of linezolid (LZD) activity
against methicillin resistant Staphylococcus aureus (MRSA) - Web
show - PDF
- J. Bulitta,
S.B. Dufull, M. Kinzig-Schippers, U. Holzgrabe, U. Stephan, F. Sörgel
(Nürnberg, Germany)
Cystic fibrosis patients are pharmacokinetically comparable to healthy
volunteers - Web
show - PDF
- Y.F. Brun,
B.H. Segal, C.G. Dennis, R. Youn, D.B. White, W.R. Greco (Buffalo, NY)
Modeling of the three antifungal agent combination (amphotericin B +
micafungin + nikkomycin Z) against Aspergillus fumigatus in vitro using
a novel response surface paradigm - WEB
show - PDF
- O.O. Okusanya,
A. Forrest, P.F. Smith (Buffalo, NY)
A novel PK/PD model for cefprozil (CPZ) vs. Hemophilus influenzae (HI)
in an in vitro infection model (IVM) - Web
show - PDF)
Full presentations
- George
Talbot, MD (Talbot Advisors, Wayne, Md)
The dwindling Pipeline of Anti-infectives, a Medical
Need and a cry for Innovation in Study Design
Web
show - PDF
- Alan
Forrest, Pharm.D. (School of Pharmacy and Pharmaceutical
Sciences, State University of New York at Buffalo, Buffalo, NY)
Patient studies modeling Surrogates and their Linkages:
MICs, Clinical Scoring, and PK/PD indices of effect
Web show
- PDF
- George
Drusano, M.D. (Ordway Research Institute, Albany, NY)
Convincing the Pharmaceutical Industry to use Surrogates
for Antibiotic Development: What is gained, and What is Lost
Web show
- PDF
- John
Powers, M.D. (US Food & Drug Adminstration, Rockville,
Md)
Role of Surrogate Markers in the development of Antibiotics,
FDA Perspective
Web show - PDF
|
